Basic Info

150 Munson Street 25 Science Park 2nd Fl
New Haven, CT 06511
(203) 772-2888
  N/A
www.helixtherapeutics.com
Preferred contact:
  N/A - President/CEO
Helix Therapeutics LLC
Profile last edited on: 1/14/2014
Business Identifier: deoxyribonucleic acid (DNA) based therapeutics
Public Profile:
Spun out of Yale University, Helix Therapeutics, Inc. develops deoxyribonucleic acid (DNA) based therapeutics. It develops novel sequence-specific gene-targeting reagents for the treatment of HIV/AIDS and common genetic diseases, such as sickle cell anemia, thalassemia, and cystic fibrosis.The mission of Helix is to establish cures for select genetic diseases using triplex-forming oligonucleotide (TFO) technology. Specific targeting of genetic information in human hematopoietic stem cells leads to stable, heritable correction of responsible mutations.

 Synopsis: Awardee Business Condition
Year Founded First SBIR Year 2008 Date of Last Award
Employee Range VC funded? IP Holdings
Revenue Range Private/Public Exchange/Symbol N/A : N/A
 Most Recent SBIR Projects
Year Phase Agency Dollars Project Title
Targeted Ccr5 Gene Inactivation Using Peptide Nucleic Acids

      

Media coverage